Cite
APA Citation
Taskinen, M., Del Prato, S., Bujas-Bobanovic, M., Louie, M. J., Letierce, A., Thompson, D., & Colhoun, H. M. (2018). efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial. Atherosclerosis, 276, 124–130. http://access.bl.uk/ark:/81055/vdc_100066658481.0x000059